Skip to main content

Falcon Genomics, Inc.

Bringing genomic solutions for breast cancer diagnosis and therapy.
Falcon Genomics Brochure
The Cancer BioChip System
Contact Us
Member Login

The goal of Falcon Genomics, Inc. is to provide cutting edge technologies for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies.

Technology Platform
Falcon Genomics' patented system, the Cancer BioChip System (CBCS™),

is the most comprehensive genomic platform for cancer testing. It combines genomic profiling of the tumor with personalized selection of targeted and efficient therapy.

Falcon Genomics' validated tests for patients with breast cancer:
-  Falcon Breast Cancer Test (BCT)
-  Falcon Tamo
-  Cancer BioChip

Recent News

October 13, 2014

Mr. Dana E. Thomas presents Falcon Genomics' Company Presentation at Life Sciences Future, Philadelphia, PA

July 29, 2014

Dr. Rula Abbud-Antaki receives 2 awards at the AACC 2014 Annual Meeting and Clinical Lab Expo for her poster presentation on the Falcon Breast Cancer Test, titled: "Identification of four molecular subclasses of Luminal Breast Cancer with Different likelihood of recurrence and response to Tamoxifen".

May 17, 2013
Falcon Genomics, Inc. receives notice of allowance for its Canadian Patent Application # 2,593,494.

ight © 2007 Falcon Genomics, Inc. All rights reserved.